Case Studies

Real-World Impact

See how leading pharmaceutical companies and research institutions are using Brainify.AI to accelerate drug development and improve patient outcomes.

Pharma Biomarker Services

Population-Scale QEEG Biomarker Analysis for a Phase 1 GAD Trial

Brainify.AI provided a pharmaceutical partner with population-scale normative QEEG data for 14 biomarkers, transforming small-trial EEG observations into interpretable proof-of-mechanism evidence for a novel CNS compound studied in generalized anxiety disorder (GAD).

DatahubFoundational Model

100K+

Normative subjects

14

Biomarkers analyzed

Applied Research

Weeks-to-Insight Opportunity Mapping from Datahub

Negev Labs uncovered new therapeutic opportunities for a promising CNS compound in under 4 weeks using Datahub, compressing 12-16 months of conventional research.

DatahubFoundational Model

6x

Faster time to insights

$250-400k

Cost savings

Clinical Trial

EEG Biomarker Discovery for Phase 2 PTSD Clinical Trial

Honeybrains Biotech partnered with Brainify.AI to identify treatment responders and improve clinical trial outcomes using our EEG Foundational Model.

Brain Measurement KitFoundational Model

150K+

Subjects in model training

Phase 2

Clinical trial

Clinical Trial Solution

Brain Measurement Kit: Ready-to-Run for Distributed Clinical Studies

Portable active dry-electrode cap, 14 g Bluetooth amplifier, offline-capable acquisition tablet, and guided software for distributed or site-based data collection.

Brain Measurement Kit

14g

Amplifier weight

~15 min

Session time

More case studies coming soon.

Want to Be Our Next Success Story?

We're partnering with leading pharmaceutical companies and research institutions. Let's discuss how Brainify.AI can accelerate your programs.